Learn more

GREEN CROSS KOREA

Overview
  • Total Patents
    119
About

GREEN CROSS KOREA has a total of 119 patent applications. Its first patent ever was published in 1986. It filed its patents most often in Republic of Korea, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are ROGER WILLIAMS HOSPITAL, PROCLARA BIOSCIENCES INC and NEUROPHAGE PHARMACEUTICALS INC.

Patent filings per year

Chart showing GREEN CROSS KOREAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kwon Byoung S 9
#2 Youn Byung S 9
#3 Baek Seung Jae 8
#4 Park Doo-Hong 6
#5 Lee Eun-Kyoung 6
#6 Choi Han 6
#7 Na Doe Sun 6
#8 Lee Jong Ho 6
#9 Jung Il Lae 6
#10 Park Young Min 6

Latest patents

Publication Filing date Title
KR20040084875A Plasmid to be inserted with variable region of human antibodies against the surface antigen of HBV
US6887852B1 Pharmaceutical preparation of recombinant factor VIII lyophilized without albumin as a stabilizer
KR20030062517A ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY AND SINGLE CHAIN Fv PREPARED THEREFROM
KR20030061568A Human antibodies against the surface antigen of HBV
KR20020096070A Immunochromatographic assay strip and assay device having transparent plastic backing and method for producing he same
KR20020078032A Kit for diagnosing non-pregnancy, and method for diagnosing non-pregnancy using the same
KR20020072349A Method of Reactivating Immobilized Urokinase Column
KR20020058146A A recombinant vaccinia virus incorporated with a gene coding glutamic acid decarboxylase and a vaccine for preventing type 1 diabetes mellitus comprising the same
KR20020050893A A process for producing a protein
KR20010089029A Reagent composition and method for diagnosing malaria antibodies
EP1162991A1 Arginine-rich anti-vascular endothelial growth factor peptides that inhibit growth and metastasis of human tumor cells by blocking angiogenesis
KR20010027299A Fibrin sealant delivery device
KR20000006448A Surface expression system of hepatitis B virus surface antigen and core antigen of hepatitis C virus by using ice-nucleation protein
WO9967366A1 Surface expression system of hepatitis b virus surface antigen and core antigen of hepatitis c virus by using ice-nucleation protein
AU3959499A Process of purifying angiogenesis inhibitors
CN1352687A A variant of c6 beta-chemokine leukotactin-1 (shLKn-1) with enhanced biological activity
KR20020008189A A Variant of C6 β-Chemokine Leukotactin-1(shLkn-1) with Enhanced Biological Activity
KR20000055980A Humanized antibody specific for HBV surface antigen pre S2 and the process for preparation thereof
KR20000037812A Inhibitors of angiogenin and plasmin
KR20000033009A Preparation of humanized antibody on surface antigen pre-s1 of hepatitis b virus